Texas · 87276

Detection Test By Immunofluorescent Technique For Influenza A Virus in Texas

Texas Medicare Avg
$15.59
0% above national avg
National Medicare Avg
$15.56
All states combined
Billed Charge (TX)
$112.78
What providers submit
Est. Commercial (TX)
$35.87
National avg: $34.86
Est. Cash / Self-Pay (TX)
$42.71
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

286
Services in TX
29
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Broussard, Crystal MD $15.53 72
Wanner, Elizabeth $15.75 54
Reliance Medlabs, Llc $15.75 20
Durling, Laura MD $15.75 18
Yllana-Shepperd, Aurora M.D. $15.75 13

Texas Pricing in Context

In Texas, CPT code 87276 (Detection Test By Immunofluorescent Technique For Influenza A Virus) carries an average Medicare payment of $15.59 — 0% above the national benchmark of $15.56. 29 providers across the state submitted claims for this procedure in 2023, performing 286 total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $112.78, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Texas lands near $35.87, with self-pay cash prices typically around $42.71. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Detection Test By Immunofluorescent Technique For Influenza A Virus cost in Texas?

The average Medicare payment for Detection Test By Immunofluorescent Technique For Influenza A Virus in Texas is $15.59, which is 0% above the national average of $15.56. Providers in TX typically bill $112.78 for this procedure.

What does Detection Test By Immunofluorescent Technique For Influenza A Virus cost with insurance in Texas?

With commercial insurance in Texas, Detection Test By Immunofluorescent Technique For Influenza A Virus costs an estimated $35.87. Without insurance, the estimated cash price is $42.71. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Detection Test By Immunofluorescent Technique For Influenza A Virus in Texas?

29 providers in Texas billed Medicare for Detection Test By Immunofluorescent Technique For Influenza A Virus in 2023, performing 286 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Detection Test By Immunofluorescent Technique For Influenza A Virus cheaper in Texas than the national average?

No — Detection Test By Immunofluorescent Technique For Influenza A Virus costs 0% above the national average in Texas. The state average Medicare payment is $15.59 compared to $15.56 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial